News & Noteworthy

Zohar wins in Delaware over botched $40 Million IPO

The Zohar Law Firm was retained to represent Emmaus Life Sciences, Inc., a pharmaceutical company currently in clinical trials for a potential cure for sickle cell disease, in a dispute with financial consultant AFH Holding & Advisory over Emmaus’ Initial Public Offering, which was supposed to take place in 2011. Emmaus sued for fraud and breach of contract, among other things. On May 15, 2013, the Delaware Superior Court granted summary judgment in favor of ZLF’s client, Emmaus.

See the press release »

Read the Opinion »